Loraz and Aminocaproic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Aminocaproic acid (aminocaproic acid). Common drug interactions include renal impairment among females and gastrointestinal haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Aminocaproic acid. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,695 Loraz users. Check the latest studies of Loraz.

What is Aminocaproic acid?

Aminocaproic acid has active ingredients of aminocaproic acid. eHealthMe is studying from 727 Aminocaproic acid users. Check the latest studies of Aminocaproic acid.



On Aug, 11, 2026

52 people who take Loraz and Aminocaproic acid together, and have interactions are studied.

Loraz and Aminocaproic acid drug interactions.

What are the common drug interactions of Loraz and Aminocaproic Acid, by gender? *:

female:

  1. Renal impairment (severely reduced kidney function)
  2. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  3. Sedation
  4. Swelling
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Thrombosis (formation of a blood clot inside a blood vessel)
  7. Unresponsive to stimuli
  8. Vascular compression
  9. Vision blurred
  10. Visual impairment

male:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  4. Delirium (wild excitement)
  5. Hepatic failure (liver failure)
  6. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  7. Neuromyopathy (disease of both muscles and nerves)
  8. Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
  9. Post procedural haemorrhage (post procedural bleeding)
  10. Pulmonary hypertension (increase in blood pressure in the lung artery)

What are the common drug interactions of Loraz and Aminocaproic Acid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cardiac arrest
  2. Nausea (feeling of having an urge to vomit)
  3. Chest pain
  4. Chloroma (green-coloured tumour)
  5. Cough
  6. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  7. Depressed level of consciousness
  8. Drug ineffective
  9. Dyspnoea (difficult or laboured respiration)
  10. Exophthalmos (bulging or protruding eyeball)

20-29:

  1. Abdominal infection
  2. Abdominal pain upper
  3. Acidosis (build-up of carbon dioxide in the blood)
  4. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  5. Asthenia (weakness)
  6. Back pain
  7. Blood cholesterol increased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Bronchopleural fistula
  10. Cardiac failure congestive

30-39:

  1. Aortic valve disease
  2. Cardiac failure congestive
  3. Cardiac valve disease (heart valve disease)
  4. Cerebral artery embolism (sudden blocking of an artery by a clot or foreign material)
  5. Cerebral infarction (less blood supply to brain resulting tissue damage)
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Kidney transplant rejection
  8. Leukaemoid reaction (elevated white blood cell count, or leukocytosis, that is a physiological response to stress or infection)
  9. Post procedural complication
  10. Pseudobulbar palsy (inability to control facial movements (such as chewing and speaking))

40-49:

  1. Apnoea (suspension of external breathing)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  4. Cardiac failure congestive
  5. Cardiogenic shock (inadequate circulation of blood)
  6. Cardiomyopathy (weakening of the heart muscle)
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  9. Cough
  10. Delirium (wild excitement)

50-59:

  1. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Septic shock (shock due to blood infection)
  6. Anaemia (lack of blood)
  7. Anuria (failure of the kidneys to produce urine)
  8. Blood creatine increased
  9. Blood urea increased
  10. Chronic kidney disease

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Cardiogenic shock (inadequate circulation of blood)
  4. Cardiomyopathy (weakening of the heart muscle)
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  7. Delirium (wild excitement)
  8. Dyspnoea (difficult or laboured respiration)
  9. Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
  10. Febrile neutropenia (fever with reduced white blood cells)

What are the existing conditions these people have? *

  1. Pain: 24 people, 46.15%
  2. Nausea (feeling of having an urge to vomit): 18 people, 34.62%
  3. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 12 people, 23.08%
  4. High Blood Pressure: 11 people, 21.15%
  5. Constipation: 9 people, 17.31%
  6. Nausea And Vomiting: 9 people, 17.31%
  7. Fever: 8 people, 15.38%
  8. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 7 people, 13.46%
  9. Anaemia (lack of blood): 7 people, 13.46%
  10. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Aminocaproic acid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loraz and Aminocaproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aminocaproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aminocaproic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and aminocaproic acid (the active ingredients of Loraz and Aminocaproic acid, respectively), and Loraz and Aminocaproic acid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: